ARMP · Armata Pharmaceuticals, Inc. · Executive Compensation
$3.52
+0.21 (+6.34%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our existing cash and cash equivalents of $24.0 million as of June 30, 2026 will not be sufficient to enable us to complete all necessary development of any potential product candidates and fund our operations for the next 12 months from the date the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q are issued. These circumstances raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$133.67M
Shares
37.18M
Volume · Oct 2
124.49K
Avg daily vol (3M)
213.24K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Deborah L. Birx | Chief Executive Officer | $1,584,176 |
| Mina Pastagia | Former Chief Medical Officer | $1,041,915 |
| Pierre Kyme | Chief Business Officer | $633,640 |
| Richard Rychlik | Former Vice President, Corporate Controller | $360,407 |
| David D. House | — | $269,438 |
| David House | Senior Vice President, Finance and Principal Financial Officer | $269,438 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Deborah L. Birx | Chief Executive Officer | $1,133,931 |
| Brian Varnum | Former Chief Executive Officer | $634,140 |
| Mina Pastagia | Former Chief Medical Officer | $463,754 |
| Erin Butler | Former Vice President, Finance Administration | $287,308 |
| Richard Rychlik | Former Vice President, Corporate Controller | $197,740 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brian Varnum | Former Chief Executive Officer | $1,639,908 |
| Mina Pastagia | Chief Medical Officer | $839,236 |
| Erin Butler | Former Vice President, Finance Administration | $529,522 |
| Steve R. Martin | Former Chief Financial Officer | $389,340 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Brian Varnum | Ph. D. Chief Executive Officer | $1,475,935 |
| Todd R. Patrick | Former Chief Executive Officer | $1,379,569 |
| Steve R. Martin | Former Chief Financial Officer | $654,805 |
| Erin Butler | Vice President, Finance & Administration | — |
| Mina Pastagia | Senior Vice President, Clinical Development | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Todd R. Patrick | Former Chief Executive Officer | $826,754 |
| Brian Varnum | Chief Executive Officer (former President and Chief Development Officer) | $611,754 |
| Steve R. Martin | Chief Financial Officer | $543,504 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Todd R. Patrick | Chief Executive Officer | $1,270,756 |
| Brian Varnum | Ph. D. President and Chief Development Officer | $1,124,156 |
| Steve R. Martin | Senior VP and Chief Financial Officer | $766,878 |
| Paul C. Grint | Former Chief Executive Officer | $694,770 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Todd R. Patrick | Chief Executive Officer | $618,000 |
| Paul C. Grint | Former Chief Executive Officer | $618,000 |
| Brian Varnum | Ph. D. President and Chief Development Officer | $448,000 |
| Steve R. Martin | Senior VP and Chief Financial Officer | $429,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David House | Chief Financial Officer | Appointed | 2026-07-20 |
| Daniel Gilmer | member of the Board | Appointed | 2026-04-27 |
| Mina Pastagia, M.D. | Chief Medical Officer | Terminated | 2024-12-04 |
| Mina Pastagia, M.D. | Chief Medical Officer | Terminated | 2024-11-15 |
| Richard Rychlik | Vice President, Corporate Controller | Terminated | 2024-09-26 |
| David House | Senior Vice President, Finance | Appointed | 2024-08-15 |
| Julianne Averill | Chief Financial Officer | Resigned | 2023-09-20 |
| Richard Rychlik | principal financial officer | Appointed | 2023-09-20 |
| Dr. Brian Varnum | member of the Company's board of directors | Resigned | 2023-07-19 |
| Dr. Brian Varnum | Chief Executive Officer | Terminated | 2023-07-19 |
| Deborah L. Birx | Board of Directors | Appointed | 2023-07-11 |
| Deborah L. Birx | Chief Executive Officer | Appointed | 2023-07-11 |
| Deborah Birx | Chief Executive Officer | Appointed | 2023-07-11 |
| Dr. Deborah Birx | member of the Board | Appointed | 2023-07-11 |
| Dr. Deborah Birx | Chief Executive Officer | Appointed | 2023-07-11 |
| Dr. Brian Varnum | Board | Resigned | 2023-07-11 |
| Dr. Brian Varnum | Chief Executive Officer | Terminated | 2023-07-11 |
| Julianne Averill | Chief Financial Officer | Appointed | 2023-05-05 |